Patel, D. et al. 2024. Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in Treatment of Patients With Polycystic Ovary Syndrome: A Systemic Review of Metabolic and Cardiovascular Outcomes. Journal For International Medical Graduates. 3, 1 (Feb. 2024). DOI:https://doi.org/10.56570/jimgs.v1i1.149.